Evidence map›Paper›PMID 19066404›Full record

ArticleJournal of lipid research2009

FAT/CD36 expression is not ablated in spontaneously hypertensive rats.

Arend Bonen, Xiao-Xia Han, Narendra N Tandon, Jan F C Glatz, James Lally, Laelie A Snook, Joost J F P Luiken

Abstract read
In one paragraph

Article in Journal of lipid research, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. How Hypertension Affects Heart Metabolism.Frontiers in physiology · 2019
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Arend BonenDepartment of Human Health and Nutritional Sciences University of -Guelph, Guelph, Ontario, N1G 2W1, Canada. abonen@uoguelph.ca
Xiao-Xia Han
Narendra N Tandon
Jan F C Glatz
James Lally
Laelie A Snook
Joost J F P Luiken

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is doubt whether spontaneously hypertensive rats (SHR; North American strain) are null for fatty acid translocase (FAT/CD36). Therefore, we examined whether FAT/CD36 is expressed in heart, muscle, liver and adipose tissue in SHR. Insulin resistance was present in SHR skeletal muscle. We confirmed that SHR expressed aberrant FAT mRNAs in key metabolic tissues; namely, the major 2.9 kb transcript was not expressed, but 3.8 and 5.4 kb transcripts were present. Despite this, FAT/CD36 protein was expressed in all tissues, although there were tissue-specific reductions in FAT/CD36 protein expression and plasmalemmal content, ranging from 26-85%. Fatty acid transport was reduced in adipose tissue (-50%) and was increased in liver (+47%). Normal rates of fatty acid transport occurred in heart and muscle, possibly due to compensatory upregulation of plasmalemmal fatty acid binding protein (FABPpm) in red (+123%) and white muscle (+110%). In conclusion, SHRs (North American strain) are not a natural FAT/CD36 null model, the North American strain of SHR express FAT/CD36, albeit at reduced levels.

Indexed as

Adipose TissueAnimalsBiological Transport, ActiveCD36 AntigensCell MembraneFatty AcidsGene ExpressionGlucoseHypertensionInsulin ResistanceLiverMaleMuscle, SkeletalMyocardiumPalmitic AcidRatsCD36 AntigensCd36 protein, ratFatty AcidsGlucosePalmitic AcidRNA, Messenger

Identifiers

PMID19066404
PMCPMC2656668

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.